🌅 Pre-Market Pulse

S&P Futures 7,253.75 ▼ -7.00 (-0.10%)	Nasdaq Futures 27,567.25 ▼ -77.25 (-0.28%)	Dow Futures 49,977.00 ▲ +79.00 (+0.16%)
10Y Treasury 4.39% ▼ -0.03%	US Dollar 98.02 ▼ -0.12 (-0.13%)	Bitcoin $77,246 ▲ +$950 (+1.24%)

Good morning! Happy May 1st. The first trading day of a new month arrives with futures pointing in different directions, which is honestly a pretty fitting way to kick off May. The Dow is nudging higher while the Nasdaq pulls back slightly, and a busy slate of earnings results is giving traders plenty to chew on before the open. Here's what's moving this morning.

👀 What to Watch Today

The earnings calendar is doing the heavy lifting today. Chevron (CVX), Estee Lauder (EL), Moderna (MRNA), and Magna International (MGA) have all reported before the open, so expect those names to set the tone early. Reactions in the first hour of trading tend to be the most telling, especially when beats are accompanied by forward guidance that either confirms or contradicts the headline number.

On the macro side, keep an eye on the dollar. The DXY is sitting at 98.02 and drifting lower, which typically provides a modest tailwind for multinationals with heavy international revenue exposure. Treasury yields are easing slightly, with the 10-year at 4.39%, and that cooling could offer some relief to growth stocks after a rough week for the Nasdaq.

The FDA advisory panel rejection of AstraZeneca's (AZN) breast cancer drug candidate is also worth monitoring. AZN shares could face selling pressure as the market digests what that setback means for its oncology pipeline. The company says it will continue working with U.S. regulators, but advisory rejections are rarely painless in the near term.

Your next chance to cash in on gold’s run [ad]

🌏 Overnight Recap

European markets opened Friday with a cautious but generally positive tone, picking up momentum from the wave of corporate earnings crossing the tape from both sides of the Atlantic. The Santander (SAN) and Sabadell (BNDSF) deal made headlines overseas after Spain's Banco Sabadell confirmed it sold UK subsidiary TSB to Banco Santander for 3.3 billion euros. That kind of strategic consolidation in European banking is getting attention from financials traders heading into the New York open.

In Asia, markets were mixed overnight as investors processed ongoing uncertainty around trade policy and currency moves. The weaker dollar is a theme that carried through Asian sessions, giving some support to export-heavy markets. Bitcoin caught a bid overnight and is sitting at $77,246, up about 1.24%, suggesting some rotation into risk assets even as equity futures wobble.

The SpaceX IPO registration story is drawing significant attention globally after Reuters reported the company has spent over $15 billion developing its Starship rocket. The sheer scale of that investment has traders speculating about valuation when the company eventually goes public, a conversation that is clearly just getting started.

Trump’s Secret Reason For Invading Iran [ad]

📊 Pre-Market Movers

Estee Lauder (EL) is among the brighter pre-market movers after beating third-quarter sales estimates on the back of strong demand in China and Europe. CEO Stephane de La Faverie's restructuring push, including another round of job cuts, appears to be gaining traction with investors who want to see leaner operations alongside top-line growth.

Moderna (MRNA) is a more complicated picture. Revenue rose in Q1 thanks to international Covid-19 vaccine sales, but the company still posted a net loss, and that combination tends to create a tug-of-war in pre-market trading. Watch for early direction on MRNA as investors weigh whether the revenue trend is sustainable without a clear path to profitability.

Harley-Davidson (HOG) is quietly in focus after the NHTSA announced a recall of 88,039 motorcycles due to an airbox issue. Recalls of this scale rarely derail a stock entirely, but they add headline risk on an otherwise busy tape. CVS (CVS) is also worth a glance after news broke about its robotic warehouse system, a potential long-term margin story that the market may begin pricing in.

Sell this, buy that [ad]

🔍 Today's Watchlist

1. CVX: Chevron beat Q1 estimates on stronger upstream performance and elevated oil prices tied to U.S.-Israeli tensions with Iran
2. EL: Estee Lauder beat Q3 sales estimates and announced more job cuts, with China and Europe driving the upside surprise
3. AZN: AstraZeneca faces post-open pressure after an FDA advisory panel rejected its breast cancer drug candidate
4. 10-Year Treasury at 4.39%: Yields easing slightly could offer a small lift to rate-sensitive growth names today
5. DXY at 98.02: A weakening dollar bears watching for multinationals reporting international revenue beats like EL and MGA

🎯 The Morning Playbook

The theme for Friday's session is selectivity. The broad indices are roughly flat in pre-market, but there is real money to be made and lost in individual names today. Earnings-driven moves in EL, CVX, MRNA, and MGA will dominate early flow, and the quality of guidance matters as much as the headline beat or miss.

For longer-term investors, the Chevron beat is worth a deeper look given the geopolitical context driving oil prices higher. Energy continues to be one of the few sectors where macro tailwinds and corporate execution are aligned right now. The AZN news is a reminder that biotech and pharma carry binary risk even for large-cap names.

As May begins, keep perspective. One mixed morning does not make a trend. The earnings season has been broadly constructive, yields are cooperating slightly, and the dollar is soft enough to help international earners. Patience and precision tend to beat panic on days like this one.

GOLD SHOCK COMING [ad]